A randomized control trial to test the effect of pegbovigrastim treatment at dry-off on plasma and milk oxylipid profiles during early mammary gland involution and the postparturient period
Open Access
- 1 July 2024
- journal article
- research article
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (7) , 5070-5089
Abstract
The early period of mammary gland involution is a critical juncture in the lactation cycle that can have significant effects on milk production and mammary gland health. Pegbovigrastim (PEG) administered 1 wk prior and on the day of parturition can enhance immune function and reduce the incidence of mastitis in the early postpartum period. Oxylipids are potent metabolites of polyunsaturated fatty acids (PUFA) and are important mediators of inflammation. The objective of this study was to evaluate effects of PEG given 1 wk before and at the day of dry-off (D0) on concentrations of oxylipids in plasma and milk from 7 d before D0 to 14 d after, as well as the effects during the first 14 d of the subsequent lactation. We hypothesized that both pro- and antiinflammatory oxylipids would vary based on initiation of mammary gland involution and that pegbovigrastim would affect oxylipid concentrations, particularly those related to leukocytes. A complete randomized blocked design was used to enroll cows into either a PEG treatment group (n = 10) or control group (n = 10; CON). Blood samples were collected -7, -2, -1, 0, 1, 2, 4, 7, and 14 d relative to dry-off and 5, 10, and 14 d postcalving. Samples were analyzed for PUFA and oxylipids in milk and plasma by ultra-performance mass spectrometry and liquid chromatography tandem quadrupole mass spectrometry, respectively. Overall, 30 lipid mediators were measured in both milk and plasma. Repeated measures analyses revealed a significant interaction of treatment by time for milk 8-iso-keto-15-prostaglandin E2, prostaglandin F2 alpha, plasma 8,12-iso-prostaglandin F alpha VI, 11-hydroxyeicosatetraenoic acid, and 12-hydroxy heptadecatienoic acid. The majority of milk PUFA and oxylipids differed significantly during early mammary gland involution and into the early postpartum period. This study demonstrated changes in oxylipids in milk secretions and plasma during early involution, and further investigation may illuminate multiple complex processes and reveal targets for optimization of mammary gland involution.Keywords
Funding Information
- Elanco
This publication has 55 references indexed in Scilit:
- Immunopathology of Mastitis: Insights into Disease Recognition and ResolutionJournal of Mammary Gland Biology and Neoplasia, 2011
- Effect of infection with bovine leukosis virus on lymphocyte proliferation and apoptosis in dairy cattleAmerican Journal of Veterinary Research, 2011
- Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammationFree Radical Biology and Medicine, 2010
- TNFα-mediated plasminogen activation on neutrophils is involved in the high plasmin activity in mammary secretion of drying-off cowsJournal of Dairy Research, 2009
- Phospholipase A2 BiochemistryCardiovascular Drugs and Therapy, 2008
- The relationship between the fatty acid composition of immune cells and their functionProstaglandins, Leukotrienes and Essential Fatty Acids, 2008
- 13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cellsBiochemical Pharmacology, 2007
- Roles of the Innate Immune System in Mammary Gland Remodeling During InvolutionJournal of Mammary Gland Biology and Neoplasia, 2007
- Secretion composition during bovine mammary involution and the relationship with mastitisInternational Journal of Biochemistry, 1987
- The effect of intramammary infection during the dry period on the milk production of the affected quarter at the start of the succeeding lactationJournal of Dairy Research, 1968